Credit Suisse’s Immune Pharmaceuticals Inc. IMNP Stock Holding History

Credit Suisse’s Portfolio IMNP Stock Details IMNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-38,399	Closed	-$7K	–	4147
2018 Q2	$7K	Buy	38,399 +5,000	+15%	+$1.41K	﹤0.01%	3944
2018 Q1	$11K	Buy	33,399 +9,895	+42%	+$4.71K	﹤0.01%	3935
2017 Q4	$14K	Buy	+23,504	New	+$22.4K	﹤0.01%	3947

Other funds holding IMNP

Intellectus Partners San Francisco, California $490M AUM 35.11% 1-Year Est. Return

Credit Suisse's IMNP Position: Q3 2018 in Review

Credit Suisse sold out of Immune Pharmaceuticals Inc. (IMNP) in Q3 2018, closing a stake of 38,399 shares — an estimated $7K sold.

Credit Suisse first reported a position in IMNP in Q4 2017 and held it in 3 quarters. The position peaked at $14K in Q4 2017. 1 fund tracked by Wall St. Rank holds IMNP as of Q3 2018.

Credit Suisse reported no remaining Immune Pharmaceuticals Inc. position as of Q3 2018 after selling out during the quarter.
Credit Suisse sold 38,399 Immune Pharmaceuticals Inc. shares in Q3 2018, an estimated $7K.
Credit Suisse first reported a position in Immune Pharmaceuticals Inc. in Q4 2017 and held it in 3 quarters.
Credit Suisse's Immune Pharmaceuticals Inc. position peaked at $14K in Q4 2017.
1 fund tracked by Wall St. Rank held Immune Pharmaceuticals Inc. as of Q3 2018.

Based on Credit Suisse's 13F filing for Q3 2018, filed 13 Nov 2018.